MedPath

Study on Feasibility of Stimulation on the Lumbar Part of the Spinal Cord to Improve Mobility Recovery in Patients With Sub-acute Spinal Cord Injury

Not Applicable
Withdrawn
Conditions
Spinal Cord Injury
Interventions
Device: STIMO-2 device implantation
Registration Number
NCT04196114
Lead Sponsor
Ecole Polytechnique Fédérale de Lausanne
Brief Summary

The STIMO-2 study aims to investigate TESS-supported rehabilitation training in sub-acute spinal cord injury (\< 6 months post-injury). The primary endpoint of this study is to assess the safety and feasibility of TESS. The preliminary effectiveness of the therapy is the secondary study endpoint. The mobility recovery status of patients, who undergo TESS-supported rehabilitation, will be assessed at 12 months post SCI, compared to their predicted recovery expectations based on standard rehabilitation program

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
All patientsSTIMO-2 device implantationAll patients implanted.
Primary Outcome Measures
NameTimeMethod
Safety Measure: occurence of Serious Adverse EventThrough study completion, until 12 months after injury

Occurrence of Serious Adverse Event that are deemed related or possibly related to study procedure or to study investigational system

Feasibility Measure: use of TESS stimulation (in minutes) for improved mobilityThrough study completion, until 12 months after injury

Measure of the absolute and relative usage of TESS (in minutes) during mobility rehabilitation sessions.

Secondary Outcome Measures
NameTimeMethod
Preliminary effectiveness: mobility assessment using SCIM-III mobility scoreThrough study completion, until 12 months after injury

This endpoint will compare each patient's SCIM-III mobility score at 12 months post Date Of Injury to historical controls.

Preliminary effectiveness: assessment of function recovery of leg motor function using the 6 mnWT distanceThrough study completion, until 12 months after injury

This endpoint will compare each patient's 6mnWT distance at 12 months post Date Of Injury to historical controls.

Trial Locations

Locations (1)

CHUV

🇨🇭

Lausanne, Vaud, Switzerland

© Copyright 2025. All Rights Reserved by MedPath